IFNA1 and Behcet disease: Although the traditional treatment options involve glucocorticoids and immunosuppressants, there is little evidence regarding their efficacy in BD.1 IFN and TNF-α antagonists have demonstrated good efficacy and are the first-line agents used to improve prognosis in BD.